757885

    544449

    ANTHEM

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Anthem Biosciences Ltd Share Price Today

    ANTHEM BIOSCIENCES LTD is currently trading at ₹784.4, down by ₹5.59 from the previous close. The stock touched an intraday high of ₹800.00 and a low of ₹779.65 during the latest trading session. Over the past one year, ANTHEM BIOSCIENCES LTD has delivered a return of 0.96%, while the stock has gained 1.93% in the last one month.

    Anthem Biosciences Ltd performance

    Today’s low Today’s high
    ₹ 779.65 ₹ 800.00
    ₹ 784.40
    52 week low 52 week high
    ₹ 579.15 ₹ 873.50
    ₹ 784.40
    Open Price ₹ 787.50
    Prev. Close ₹ 790.00
    Volume (Shares) 326748.00
    Total traded value ₹ 2563.01
    Upper Circuit ₹ 948.00
    Lower Circuit ₹ 632.00
    info

    Investment Returns

    Over 1 Month 1.93% Over 3 Months 1.90% Over 6 Months 33.25% Over 1 Year 0.96%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Anthem Biosciences Ltd fundamentals


    • Market cap (Cr) 44,177.00
    • P/E Ratio (TTM) 71.26
    • Beta 0.70
    • Book Value / share 56.55
    • Return on equity 23.70%
    • EPS (TTM) 11.40
    • Dividend yield 0.25%
    • Net profit/quarter (Cr) 102.01
    info icon alternate text
    • Market cap (Cr) 44,126.30
    • P/E Ratio (TTM) 71.26
    • Beta 0.68
    • Book Value / share 56.55
    • Return on equity 23.70%
    • EPS (TTM) 11.40
    • Dividend yield 0.25%
    • Net profit/quarter (Cr) 102.01
    info icon alternate text

    Anthem Biosciences Ltd Financials

    Open financial information
    Revenue
    Net income
    Particulars JUN 2026 (Values in Cr)
    Revenue 383.84
    Operating Expense 276.08
    Net Profit 102.01
    Net Profit Margin (%) 26.57
    Earnings Per Share (EPS) 1.81
    EBITDA 159.43
    Effective Tax Rate (%) 25.19
    Particulars MAR 2026 (Values in Cr)
    Revenue 582.50
    Operating Expense 343.37
    Net Profit 211.67
    Net Profit Margin (%) 36.33
    Earnings Per Share (EPS) 3.77
    EBITDA 328.58
    Effective Tax Rate (%) 29.61
    Particulars DEC 2025 (Values in Cr)
    Revenue 416.58
    Operating Expense 281.40
    Net Profit 112.12
    Net Profit Margin (%) 26.91
    Earnings Per Share (EPS) 2.00
    EBITDA 177.99
    Effective Tax Rate (%) 25.30
    Particulars SEP 2025 (Values in Cr)
    Revenue 552.23
    Operating Expense 352.72
    Net Profit 198.43
    Net Profit Margin (%) 35.93
    Earnings Per Share (EPS) 3.54
    EBITDA 279.45
    Effective Tax Rate (%) 21.66
    Particulars JUN 2025 (Values in Cr)
    Revenue 538.01
    Operating Expense 366.80
    Net Profit 148.34
    Net Profit Margin (%) 27.57
    Earnings Per Share (EPS) 2.65
    EBITDA 223.16
    Effective Tax Rate (%) 25.43
    Particulars MAR 2026 (Values in Cr)
    Revenue 2089.31
    Operating Expense 1344.31
    Net Profit 670.56
    Net Profit Margin (%) 32.09
    Earnings Per Share (EPS) 11.95
    EBITDA 1009.19
    Effective Tax Rate (%) 25.74
    Particulars MAR 2025 (Values in Cr)
    Revenue 1840.65
    Operating Expense 1238.66
    Net Profit 506.19
    Net Profit Margin (%) 27.50
    Earnings Per Share (EPS) 9.05
    EBITDA 798.45
    Effective Tax Rate (%) 28.84
    Particulars MAR 2024 (Values in Cr)
    Revenue 1417.54
    Operating Expense 1003.28
    Net Profit 374.78
    Net Profit Margin (%) 26.43
    Earnings Per Share (EPS) 6.61
    EBITDA 575.40
    Effective Tax Rate (%) 22.68
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 54.16
    ROE % 21.71
    ROCE % 29.30
    Total Debt to Total Equity 0.03
    EBITDA Margin 45.44
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 43.10
    ROE % 20.82
    ROCE % 28.24
    Total Debt to Total Equity 0.08
    EBITDA Margin 41.03
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 34.43
    ROE % 20.04
    ROCE % 23.98
    Total Debt to Total Equity 0.10
    EBITDA Margin 40.07
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 30.51
    ROE % 22.25
    ROCE % 27.36
    Total Debt to Total Equity 0.05
    EBITDA Margin 48.81
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 1543.93
    ROE % 39.44
    ROCE % 49.35
    Total Debt to Total Equity 0.07
    EBITDA Margin 49.87
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 56.70
    ROE % 23.70
    ROCE % 30.98
    Total Debt to Total Equity 0.03
    EBITDA Margin 48.31
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 44.24
    ROE % 22.98
    ROCE % 30.46
    Total Debt to Total Equity 0.06
    EBITDA Margin 43.39
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 34.58
    ROE % 20.40
    ROCE % 24.74
    Total Debt to Total Equity 0.08
    EBITDA Margin 40.60
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 30.53
    ROE % 22.27
    ROCE % 27.47
    Total Debt to Total Equity 0.05
    EBITDA Margin 48.86
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 1544.46
    ROE % 39.48
    ROCE % 49.38
    Total Debt to Total Equity 0.07
    EBITDA Margin 49.90
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 274.88
    Total Assets 3429.29
    Total Liabilities 3429.29
    Total Equity 3042.51
    Share Outstanding 56
    Price to Book Ratio 11.57
    Return on Assets (%) 17.25
    Return on Capital (%) 19.13
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 172.28
    Total Assets 2807.58
    Total Liabilities 2807.58
    Total Equity 2409.86
    Share Outstanding 55
    Price to Book Ratio 0.00
    Return on Assets (%) 16.07
    Return on Capital (%) 17.92
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 184.35
    Total Assets 2398.11
    Total Liabilities 2398.11
    Total Equity 1924.65
    Share Outstanding 55
    Price to Book Ratio 0.00
    Return on Assets (%) 15.31
    Return on Capital (%) 17.03
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 342.84
    Total Assets 2014.45
    Total Liabilities 2014.45
    Total Equity 1740.66
    Share Outstanding 57
    Price to Book Ratio 0.00
    Return on Assets (%) 19.12
    Return on Capital (%) 20.65
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 348.90
    Total Assets 1618.86
    Total Liabilities 1618.86
    Total Equity 1354.99
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 25.05
    Return on Capital (%) 29.17
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 269.85
    Total Assets 3530.84
    Total Liabilities 3530.84
    Total Equity 3184.70
    Share Outstanding 56
    Price to Book Ratio 11.57
    Return on Assets (%) 18.99
    Return on Capital (%) 20.75
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 166.25
    Total Assets 2835.56
    Total Liabilities 2835.56
    Total Equity 2473.21
    Share Outstanding 55
    Price to Book Ratio 0.00
    Return on Assets (%) 17.85
    Return on Capital (%) 19.6
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 183.84
    Total Assets 2324.22
    Total Liabilities 2324.22
    Total Equity 1933.07
    Share Outstanding 55
    Price to Book Ratio 0.00
    Return on Assets (%) 16.12
    Return on Capital (%) 17.85
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 342.79
    Total Assets 1993.01
    Total Liabilities 1993.01
    Total Equity 1741.61
    Share Outstanding 57
    Price to Book Ratio 0.00
    Return on Assets (%) 19.35
    Return on Capital (%) 20.78
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 348.86
    Total Assets 1619.17
    Total Liabilities 1619.17
    Total Equity 1355.46
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 25.07
    Return on Capital (%) 29.19
    Particulars MAR 2026 (Values in Cr)
    Net Income 824.24
    Cash from Operations 1048.48
    Cash from Investing -701.62
    Cash from Financing -39.99
    Net change in Cash 102.86
    Free Cash Flow 1259.65
    Particulars MAR 2025 (Values in Cr)
    Net Income 656.86
    Cash from Operations 429.55
    Cash from Investing -146.56
    Cash from Financing -135.65
    Net change in Cash -11.66
    Free Cash Flow 690.75
    Particulars MAR 2024 (Values in Cr)
    Net Income 477.31
    Cash from Operations 260.15
    Cash from Investing -221.45
    Cash from Financing -77.18
    Net change in Cash -158.48
    Free Cash Flow 369.57
    Particulars MAR 2023 (Values in Cr)
    Net Income 497.29
    Cash from Operations 420.98
    Cash from Investing -376.01
    Cash from Financing 63.97
    Net change in Cash -6.05
    Free Cash Flow 599.66
    Particulars MAR 2022 (Values in Cr)
    Net Income 546.14
    Cash from Operations 455.91
    Cash from Investing -205.45
    Cash from Financing 180.67
    Net change in Cash 308.13
    Free Cash Flow 478.29
    Particulars MAR 2026 (Values in Cr)
    Net Income 903.07
    Cash from Operations 1093.41
    Cash from Investing -741.99
    Cash from Financing -43.54
    Net change in Cash 103.87
    Free Cash Flow 1233.39
    Particulars MAR 2025 (Values in Cr)
    Net Income 711.42
    Cash from Operations 459.45
    Cash from Investing -249.16
    Cash from Financing -68.47
    Net change in Cash -17.18
    Free Cash Flow 591.24
    Particulars MAR 2024 (Values in Cr)
    Net Income 484.77
    Cash from Operations 284.40
    Cash from Investing -191.75
    Cash from Financing -131.59
    Net change in Cash -158.94
    Free Cash Flow 388.25
    Particulars MAR 2023 (Values in Cr)
    Net Income 497.78
    Cash from Operations 433.98
    Cash from Investing -377.90
    Cash from Financing 52.85
    Net change in Cash -6.07
    Free Cash Flow 612.66
    Particulars MAR 2022 (Values in Cr)
    Net Income 546.59
    Cash from Operations 456.34
    Cash from Investing -205.77
    Cash from Financing 180.67
    Net change in Cash 308.24
    Free Cash Flow 478.73
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.89 12.82 1.49 236.72 23.12 38.85
    BLISS GVS PHARMA LTD. 458.05 36.82 4.07 4857.91 118.35 552.90
    CIPLA LTD 1473.45 33.26 3.45 119031.97 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 451.45 21.12 3.26 1328.66 256.40 480.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.89 21.60 3.97 236.72 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 516.80 23.16 4.03 1494.10 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8179.35 106.89 23.42 20448.38 7630.00 9850.00
    BLISS GVS PHARMA LTD. 458.05 49.52 4.20 4857.91 118.35 552.90

    Anthem Biosciences Ltd shareholding pattern

    Holding
    12.52%
    71.41%
    2.57%
    13.47%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    Anthem Biosciences Ltd Technicals Summary

    784.40 -0.70 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 784.40
    • 26 Days 773.10
    • 10 Days 779.70
    • 50 Days 765.90
    • 12 Days 778.30
    • 100 Days 749.00
    • 20 Days 774.70
    • 200 Days 736.80
    785.08 PIVOT
    First Support 774.17 First Resistance 794.82 Second Support 764.43 Second Resistance 805.73 Third Support 753.52 Third Resistance 815.47
    RSI 57.71 ADX 32.84 MACD 5.14 Williams % R -22.92 Commodity Channel Index (CCI) 104.23
    Date 2026-07-29 Week 676126.00 Same Day 184821.00 Month 485689.00
    1 Year 0.70 3 Year 0.72
    Over 1 Month
    1.93% down
    Over 1 Year
    0.96% down
    Over 3 Months
    1.90% down
    Over 3 Years
    0.00% down
    Over 6 Months
    33.25% down
    Over 5 Years
    0.00% down

    Anthem Biosciences Ltd Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    25 Jun 2026 2.0 Final 26 Jun 2026 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    25 Jun 2026 2.0 Final 26 Jun 2026 Equity shares

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Anthem Biosciences Ltd?

    Answer Field

    Anthem Biosciences Ltd share price is for NSE ₹ 784.40 & for BSE ₹ 783.50 as on Jul 30 2026 03:30 PM.

    What is the Market Cap of Anthem Biosciences Ltd Share?

    Answer Field

    The market cap of Anthem Biosciences Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 30 2026 03:30 PM.

    What is the 52 Week High and Low of Anthem Biosciences Ltd?

    Answer Field

    The 52 Week High and Low of Anthem Biosciences Ltd for NSE is ₹ 873.50 and ₹ 579.15 and for BSE is ₹ 873.25 and ₹ 579.45.

    What is 1 year return for Anthem Biosciences Ltd?

    Answer Field

    The 1 year returns on the stock has been 0.96%.

    What is the P/E Ratio of Anthem Biosciences Ltd Share?

    Answer Field

    As on Jul 30 2026 03:30 PM the price-to-earnings (PE) ratio for Anthem Biosciences Ltd share is 71.26.

    What is the PB ratio of Anthem Biosciences Ltd Share?

    Answer Field

    As on Jul 30 2026 03:30 PM, the price-to-book (PB) ratio for Anthem Biosciences Ltd share is 56.55.

    How to Buy Anthem Biosciences Ltd Share?

    Answer Field

    You can trade in Anthem Biosciences Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Anthem Biosciences Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Anthem Biosciences Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Anthem Biosciences Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |